Project Grant R00DK136503
- Federal Grant Award Summary The University of Colorado-Denver received a $129,619 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) beginning September 1, 2025, and extending through May 31, 2030. This research initiative investigates the interactions between the gut microbiome, intestinal development, and metabolic health in offspring affected by fetal...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Columbia University's Health Sciences Division a Project Grant of $246,750 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), with an award date of August 15, 2025, and a completion date of August 14, 2027. This research project investigates the mechanisms of pancreatic inflammation in obesity, specifically examining how obesity affects...
- Federal Grant Award Summary The University of Colorado-Denver received a $791,520 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective February 4, 2026, with a completion date of November 30, 2029. This award funds research investigating the role of antigen-specific T cell responses in metabolic dysfunction-associated steatohepatitis (MASH), a...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Regents of the University of Colorado a Project Grant of $551,250 under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on February 19, 2026, with completion scheduled for January 31, 2029. This research project focuses on elucidating the molecular mechanisms of vesicle fusion regulation in metabolic pathways, specifically examining how...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded $1,285,172 to The Research Foundation for the State University of New York on March 15, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This project grant, extending through January 31, 2030, supports research examining the developmental trajectories of reinforcer pathology and childhood obesity. The research investigates how...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded University of Colorado-Denver a $2,076,999 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 15, 2025, with a completion date of September 14, 2029. This four-year research initiative focuses on investigating paneth cell mitochondrial dysfunction and its role in intestinal homeostasis, with particular emphasis on...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $3.1 million Project Grant to Boston Children's Hospital under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) for a four-year research initiative spanning September 3, 2025, through September 2, 2029. The research will investigate the role of lipogenic pathways in intestinal remodeling following Roux-en-Y gastric bypass (RYGB) surgery,...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $786,216 Project Grant to the University of California, Los Angeles (UCLA) on August 28, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This four-year research initiative, concluding June 30, 2029, supports fundamental biomedical research investigating the post-transcriptional regulation of hepatokines and their role in systemic...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $812,621 Project Grant to the University of Pittsburgh under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 15, 2025, with a completion date of July 31, 2030. Principal Investigator Alison B. Kohan and Multi-Principal Investigator C.A. Hodges will conduct research examining the role of the cystic fibrosis transmembrane receptor...
- Federal Project Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases awarded a $756,480 Project Grant to The Regents of The University of Colorado (University of Colorado-Denver) on September 5, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, which extends through June 30, 2030, aims to address evidence gaps in the clinical application of two new medication classes for Type 2 Diabetes...
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a Project Grant of $248,965 to the University of Colorado-Denver (effective March 1, 2026 through February 28, 2029) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports a longitudinal research study led by Dr. Catherine Cohen, PhD, RDN, investigating the relationship between pancreatic fat and volume characteristics and metabolic health outcomes in adolescents. The research leverages the Healthy Start Study, an established pre-birth cohort of approximately 1,400 mother-child pairs in Colorado, by adding quantitative magnetic resonance imaging (MRI) sequences to characterize pancreatic traits when offspring reach adolescence (ages 10-15 years). The project addresses critical gaps in pediatric metabolic disease research by examining prospective associations between early nutritional and growth patterns and pancreatic imaging biomarkers, while assessing interindividual variation in pancreatic fat and volume in relation to child adiposity measures and other metabolic characteristics. This research contributes to understanding Type 2 Diabetes (T2D) pathogenesis in youth beyond total body adiposity, with potential implications for identifying metabolic risk factors and informing prevention strategies in pediatric populations.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $249.0k | 2/11/26 |